Is nalidixic acid resistance linked to clinical virulence in Salmonella enterica serovar Typhi infections?

Journal of Medical Microbiology

Volumn 57, Issue 8, 2008, Pages 1046-1048

  Kadhiravan, Tamilarasu ^a   Wig, Naveet ^a   Renuka, K ^a   Kapil, Arti ^a   Kabra, Sushil K ^a   Misra, Anoop ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CEPHALOSPORIN; NALIDIXIC ACID; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BLOOD CULTURE; DISEASE SEVERITY; LETTER; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; SALMONELLA ENTERICA; SALMONELLOSIS; SEROTYPE; STATISTICAL SIGNIFICANCE;

ADOLESCENT; ADULT; ANTI-INFECTIVE AGENTS; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; MALE; NALIDIXIC ACID; SALMONELLA TYPHI; SURVIVAL ANALYSIS; TYPHOID FEVER; VIRULENCE;

EID: 50249188947     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.47822-0     Document Type: Letter

References (12)

1. Bland, J. M. & Altman, D. G. (1998). Survival probabilities (the Kaplan-Meier method). BMJ 317, 1572.
2. Bland, J. M. & Altman, D. G. (2004). The logrank test. BMJ 328, 1073.
3. Freedman, D. O., Weld, L. H., Kozarsky, P. E., Fisk, T., Robins, R., von Sonnenberg, F., Keystone, J. S., Pandey, P., Cetron, M. S. & other authors (2006). Spectrum of disease and relation to place of exposure among ill returned travelers. N Engl J Med 354, 119-130.
4. Hakanen, A., Kotilainen, P., Jalava, J., Siitonen, A. & Huovinen, P. (1999). Detection of decreased fluoroquinolone susceptibility in Salmonellas and validation of nalidixic acid screening test. J Clin Microbiol 37, 3572-3577.
5. Kadhiravan, T., Wig, N., Kapil, A., Kabra, S. K., Renuka, K. & Misra, A. (2005). Cinical outcomes in typhoid fever: adverse impact of infection with nalidixic acid-resistant Salmonella typhi. BMC Infect Dis 5, 37.
6. Nkemngu, N. J., Asonganyi, E. D. & Njunda, A. L. (2005). Treatment failure in a typhoid patient infected with nalidixic acid resistant S. enterica serovar Typhi with reduced susceptibility to ciprofloxacin: a case report from Cameroon. BMC Infect Dis 5, 49.
7. Parry, C. M. (2004). The treatment of multidrug-resistant and nalidixic acid-resistant typhoid fever in Viet Nam. Trans R Soc Trop Med Hyg 98, 413-422.
8. Parry, C. M., Hien, T. T., Dougan, G., White, N. J. & Farrar, J. J. (2002). Typhoid fever. N Engl J Med 347, 1770-1782.
9. Rahman, M., Siddique, A. K., Shoma, S., Rashid, H., Salam, M. A., Ahmed, Q. S., Nair, G. B. & Breiman, R. F. (2006). Emergence of multidrug-resistant Salmonella enterica serotype Typhi with decreased ciprofloxacin susceptibility in Bangladesh. Epidemiol Infect 134, 433-438.
10. Renuka, K., Sood, S., Das, B. K. & Kapil, A. (2005). High-level ciprofloxacin resistance in Salmonella enterica serotype Typhi in India. J Med Microbiol 54, 999-1000.
11. Slinger, R., Desjardins, M., McCarthy, A. E., Ramotar, K., Jessamine, P., Guibord, C. & Toye, B. (2004). Suboptimal clinical response to ciprofloxacin in patients with enteric fever due to Salmonella spp. with reduced fluoroquinolone susceptibility. BMC Infect Dis 4, 36.
12. Wain, J., Diep, T. S., Ho, V. A., Walsh, A. M., Nguyen, T. T., Parry, C. M. & White, N. J. (1998). Quantitation of bacteria in blood of typhoid fever patients and relationship between counts and clinical features, transmissibility, and antibiotic resistance. J Clin Microbiol 36, 1683-1687.